medigraphic.com
ISSN 1561-3003 (Electronic)

2022, Number 1

<< Back Next >>

Rev Cubana Hig Epidemiol 2022; 59 (1)

Main symptoms in COVID-19 patients treated at the primary health care level

Quesada AC

Language: Spanish
References: 29
Page: 1-14
PDF size: 449.20 Kb.


ABSTRACT

Introduction: The high transmission of COVID-19 poses great challenges to the health care systems of the countries. With the early identification of the symptoms and its subsequent confirmation, patient care is improved and the risk of contagion is reduced.
Objective: To identify the main symptoms of COVID-19 patients when seeking for medical assistance during the first quarter of 2021 in the health area.
Methods: A descriptive cross-sectional study conducted from January to June 2021 at the University Teaching Polyclinic “Mario Muñoz Monroy” in Habana del Este municipality. The sample consisted of 262 patients aged 5 to 95 with a positive RT-PCR, who sought medical assistance at the specialized COVID-19 consultation. Information was retrieved from the statistical records and the epidemiological surveys from the departments of Statistics and Hygiene and Epidemiology.
Results: In the surveys, 804 symptoms were identified, of which 51.86 % occurred among females and 48.31%, among males. The age group between 20 and 64 years presented the greatest symptomatology. The most recurrent symptoms in this group were cough, rhinorrhea, and fever; while loss of taste, anorexia, expectoration, and abdominal pain were documented to a lesser extent.
Conclusions: Patients of different ages and sex suffer from COVID-19. Symptomatic patients manifest a combination of respiratory and digestive symptoms, with predominance of the former at the time of consultation.


REFERENCES

  1. World Health Organization. Coronavirus disease (COVID-19) pandemic. Geneva: WHO; 2019 [acceso 01/05/2021]. Disponible en: Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 1.

  2. Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al2. . Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J. Infect. 2020 [acceso 01/05/2021];80(6):656-65. Disponible en: Disponible en: https://doi.org/10.1016/j.jinf.2020.03.041 2.

  3. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al3. . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-523. DOI: https://doi.org/10.1016/S0140-6736(20)30154-93.

  4. Acosta Torres JR, Pérez Cutiño M, Rodríguez Prieto M, Morales González A. COVID-19 en pediatría: aspectos clínicos, epidemiológicos, inmunopatogenia, diagnóstico y tratamiento. Rev. Cubana Pediatr. 2020 [acceso 01/05/2021];92 (suppl):e1152. Disponible en: Disponible en: http://www.revpediatria.sld.cu/index.php/ped/article/view/1152 4.

  5. Ministerio de Salud Pública. Protocolo de Actuación Nacional para la COVID 19 (versión 1.6). La Habana: Minsap; 2021 [acceso 01/05/2021]. Disponible en: Disponible en: https://files.sld.cu/editorhome/2021/03/28/ministerio-de-salud-publica-protocolo-de-actuacion-nacional-para-la-covid-19-version-1-6-28-marzo-2021/ 5.

  6. Asociación Médica Mundial. Declaración de Helsinki de la AMM - Principios éticos para las investigaciones médicas en seres humanos. Fortaleza: Brasil; 2013 [acceso 01/05/2021]. Disponible en: Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/ 6.

  7. Sama IE, Ravera A, Santema BT, van Goor H, Maaten JMt, Cleland JGF, et al7. . Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020;41(19):1810-17. DOI: https://doi.org/10.1093/eurheartj/ehaa3737.

  8. Almaguer Mederos LE, Cuello Almarales D, Almaguer Gotay D. Rol de los genes ACE2 y TMPRSS2 en la susceptibilidad o gravedad de la COVID-19. Anales ACC. 2020 [acceso 01/05/2021];10(2). Disponible en: Disponible en: http://www.revistaccuba.sld.cu/index.php/revacc/article/view/799/860 8.

  9. Cantero MT. Las estadísticas sanitarias y la invisibilidad por sexo y de género durante la epidemia de COVID-19. Gac Sanit. 2020 [acceso 01/05/2021];35(1):95-8. Disponible en: Disponible en: https://www.gacetasanitaria.org/es-las-estadisticas-sanitarias-invisibilidad-por-articulo-S0213911120300911 9.

  10. Garrido Tapia EJ, Manso López AM, Salermo Reyes Md, Ramírez Ramírez G, Pérez Rodríguez VR. Características clínico-epidemiológicas y algunas reflexiones sobre la COVID-19 en Holguín, Cuba, 2020. Correo Cient. Méd. 2020 [acceso 04/06/2021];24(3). Disponible en: Disponible en: http://revcocmed.sld.cu/index.php/cocmed/article/view/3717 10.

  11. Hierrezuelo Rojas N, González Fernández P, Leon Gilart A, Cordero Castillo F. Caracterización clínico-epidemiológica de pacientes con la COVID-19 en el policlínico Ramón López Peña. Rev Cubana Hig Epidemiol. 2021 [acceso 04/06/2021];58. Disponible en: Disponible en: http://www.revepidemiologia.sld.cu/index.php/hie/article/view/1117 11.

  12. Lassale C, Gaye B, Hamer M, Gale CR, Batty GD. Ethnic disparities in hospitalisation for COVID-19 in England: The role of socioeconomic factors, mental health, and inflammatory and pro-inflammatory factors in a community-based cohort study. Brain Behav Immunol. 2020 [acceso 05/05/2021];88:44-9. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/pii/S0889159120311016 12.

  13. Medina-Fuentes G, Carbajales-León EB, Figueredo-González Y, Carbajales-León AI, Silva-Corona I. Características clínico epidemiológicas de pacientes positivos a la COVID-19 pertenecientes al policlínico “Joaquín de Agüero y Agüero”, Camagüey. Rev. Electrón "Dr. Zoilo E. Marinello Vidaurreta". 2020 [acceso 02/04/2021];45(4). Disponible en: Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/2352 13.

  14. Machhi J, Herskovitz J, Senan A, Dutta D, Nath B, Oleynikov MD, et al14. . The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. 2020 [acceso 02/04/2021];15(3):359-86. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373339/ 14.

  15. World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020. Geneva: WHO ; 2020 [acceso 2/04/2021]. Disponible en: Disponible en: https://www.who.int/publications-detail/clinical-management-of-covid-19 15. . [ Links ]

  16. Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR, et al16. . Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med. 2020 [acceso 02/04/2021];382:2081-90.Disponible en: Disponible en: https://www.nejm.org/doi/full/10.1056/nejmoa2008457 16.

  17. Díaz Colina JA, Interian Morales MT, López Hernández IC, Yanes Morales CD, Peregrín Baquero D. Aspectos clínico-epidemiológicos en 36 niños cubanos con COVID-19. Rev Cubana Pediatr. 2020 [acceso 02/04/2021];92(Suppl):e1261. Disponible en: Disponible en: http://www.revpediatria.sld.cu/index.php/ped/article/view/1261 17.

  18. Yonker LM, Shen K, Kinane TB. Lessons unfolding from pediatric cases of COVID-19 disease caused by SARS-CoV-2 infection. Pediatr Pulmonol. 2021 [acceso 02/04/2021];55(5):1085-6. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32243722/ 18.

  19. Centers for Disease Control and Prevention. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. EEUU: CDC; 2020 [acceso 02/04/2021]. Disponible en: Disponible en: https://www.cdc.gov/mmwr/volumes/69/wr/mm6914e4.htm 19.

  20. Jin YH, Zhan QY, Peng ZY, Ren XQ, Yin XT, Cai L, et al20. . Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version). Mil Med Res. 2020;7(41):1-33.DOI: https://doi.org/10.1186/s40779-020-00270-820.

  21. Ramírez González AD, Montero Castrillón M, Vázquez Vázquez L. Caracterización de pacientes con COVID-19 en una unidad cuidados intensivos. Rev Cubana Med Trop. 2021 [acceso 04/06/2021];73(1):e592. Disponible en: Disponible en: http://www.revmedtropical.sld.cu/index.php/medtropical/article/view/592 21.

  22. Castellanos Rabanal O, Quevedo Leyva S, Cesar Carrera Y. Características clínico-epidemiológicas de pacientes hospitalizados por la COVID-19 en México, abril-junio 2020. Rev Cubana Hig Epidemiol. 2021 [acceso 04/06/2021];58:e1070. Disponible en: Disponible en: http://www.revepidemiologia.sld.cu/index.php/hie/article/view/1070 22.

  23. Bandera Jiménez DC, Morandeira Padrón H, Valdés García LE, Rodríguez Valdés A, Sagaró del Campo N, Palú Orozco A, et al23. . Morbilidad por COVID-19: análisis de los aspectos epidemiológicos, clínicos y diagnósticos. Rev Cubana Med Trop. 2020 [acceso 04/06/2021];72(3):e574. Disponible en: Disponible en: http://www.revmedtropical.sld.cu/index.php/medtropical/article/view/574 23.

  24. European Center for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK - seventh update. Stockholm: ECDC; 2020 [acceso 04/06/2021]. Disponible en: Disponible en: https://www.ecdc.europa.eu/sites/default/files/documents/RRAseventh-update-Outbreak-of-coronavirus-disease-COVID-19.pdf 24.

  25. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Geneva: WHO ; 2020 [acceso 04/06/2021]. Disponible en: Disponible en: https://www.who.int/publications/i/item/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19) 25.

  26. D’Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management. Clin Gastroenterol Hepatol. 2020 [acceso 04/06/2021];18(8):1663-72. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32278065/ 26.

  27. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al27. . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 [acceso 04/06/2021];395(10223):514-23. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/pii/S0140673620301549?via%3Dihub 27.

  28. Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al28. . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 [acceso 04/06/2021];58(4):711-12. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266766/ 28.

  29. She J, Liu L, Liu W. COVID-19 epidemic: disease characteristics in children. J Med Virol. 2021 [acceso 04/06/2021];92 (7):747-54. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32232980/ 29.




2020     |     www.medigraphic.com